跳至主要内容
临床试验/NCT04573946
NCT04573946进行中(未招募)不适用

VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 25,871 人开始时间: 2019年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
25,871
试验地点
1
主要终点
Number of Fractures

研究概览

简要总结

Vitamin D supplements are widely promoted for bone health. Both vitamin D and vitamin K are important for deposition of calcium in bone, but little is known about the relationship of vitamin K status and bone health.

详细描述

The goal of VITAL: Interrelationship of Vitamin D and Vitamin K on Bone is to test whether vitamin K status is associated with incident fractures in a case-cohort design or modifies the randomized effects of vitamin D supplementation vs. placebo on 2-year changes in bone density and structure outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Participants in VITAL (NCT 01169259) study who met the following criteria of the parent trial are eligible to participate in this ancillary study:
  • be men aged 50 years and older or women aged 55 years and older
  • have no history of cardiovascular disease or cancer (excluding non-melanoma skin cancer)
  • have none of the following: allergy to soy or fish, hypercalcemia, renal failure or dialysis, severe liver disease, hypo- or hyperparathyroidism, sarcoidosis or other granulomatous diseases, or any other serious illnesses
  • consume ≤ 1200 mg/d of calcium for the duration of the trial
  • consume ≤ 800 IU of vitamin D for duration of the trial
  • refrain from taking fish oil supplements for the duration of the trial

排除标准

  • - For aims 2 and 3, those who are using bisphosphonates currently or within the past 2 years, or other bone-active medications currently or within the past year are not eligible for this study

研究组 & 干预措施

Vitamin D + fish oil

Active Comparator

干预措施: Omega-3 fatty acids (fish oil) (Drug)

Vitamin D placebo + fish oil placebo

Placebo Comparator

干预措施: Fish oil placebo (Dietary Supplement)

Vitamin D + fish oil

Active Comparator

干预措施: Vitamin D3 (Dietary Supplement)

Vitamin D placebo + fish oil placebo

Placebo Comparator

干预措施: Vitamin D3 placebo (Dietary Supplement)

Vitamin D + fish oil placebo

Active Comparator

干预措施: Vitamin D3 (Dietary Supplement)

Vitamin D placebo + fish oil

Active Comparator

干预措施: Vitamin D3 placebo (Dietary Supplement)

Vitamin D placebo + fish oil

Active Comparator

干预措施: Omega-3 fatty acids (fish oil) (Drug)

Vitamin D + fish oil placebo

Active Comparator

干预措施: Fish oil placebo (Dietary Supplement)

结局指标

主要结局

Number of Fractures

时间窗: 2 years

The effect of low vitamin K status (with or without vitamin D supplementation) on the number of new total, non-vertebral and hip fractures.

次要结局

  • Change in Bone Strength(2 years)
  • Change in Trabecular Bone Score(2 years)
  • Change in Volumetric Bone Mineral Density(2 years)
  • Change in Areal Bone Density(2 years)
  • Change in Cortical Thickness(2 years)
  • Concentration of Urine Calcium(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Meryl LeBoff

Director of Skeletal Health and Osteoporosis Center

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验